NBP
Price:
$1.49
Market Cap:
$1.16B
NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering immuno-oncology treatments for cancer patients within the United States. Its development pipeline features several significant drug candidates: givastomig, a bispecific antibody currently in Phase 1b clinical trials for gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, another bispecific antibody, which is undergoing Phase 1 clinical evaluation for solid tumors. The company maintains a strategic licensing agreement with Ferring International Center SA, encompassing the research, development, manufacturing, import, use, and commercialization rights for FE301, an interleukin-6 inhibitor. Addi...[Read more]
Industry
Biotechnology
IPO Date
2020-01-17
Stock Exchange
NASDAQ
Ticker
NBP
According to NovaBridge Biosciences’s latest financial reports and current stock price. The company's current ROE is -0.50%. This represents a change of -85.80% compared to the average of -3.50% of the last 4 quarters.
The mean historical ROE of NovaBridge Biosciences over the last ten years is -133.56%. The current -0.50% ROE has changed -99.63% with respect to the historical average. Over the past ten years (40 quarters), NBP's ROE was at its highest in in the December 2020 quarter at 18.51%. The ROE was at its lowest in in the June 2020 quarter at -121.28%.
Average
-133.56%
Median
-72.66%
Minimum
-604.20%
Maximum
42.18%
Discovering the peaks and valleys of NovaBridge Biosciences ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 624.93%
Maximum Annual ROE = 42.18%
Minimum Annual Increase = -3994.79%
Minimum Annual ROE = -604.20%
| Year | ROE | Change |
|---|---|---|
| 2025 | -20.03% | 81.29% |
| 2024 | -11.05% | -98.17% |
| 2023 | -604.20% | 624.93% |
| 2022 | -83.35% | -74.43% |
| 2021 | -325.94% | -3994.79% |
| 2020 | 8.37% | -106.18% |
| 2019 | -135.40% | -421.02% |
| 2018 | 42.18% | -158.05% |
The current ROE of NovaBridge Biosciences (NBP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-211.76%
5-year avg
-208.91%
10-year avg
-133.56%
NovaBridge Biosciences’s ROE is less than Galectin Therapeutics Inc. (21.05%), greater than Design Therapeutics, Inc. (-33.07%), greater than DiaMedica Therapeutics Inc. (-77.09%), greater than Aura Biosciences, Inc. (-78.12%), greater than Rocket Pharmaceuticals, Inc. (-70.79%), greater than Annexon, Inc. (-101.19%), greater than Alpha Tau Medical Ltd. (-73.23%), greater than LB Pharmaceuticals Inc Common Stock (-17.68%), greater than enGene Holdings Inc. (-55.83%), greater than Altimmune, Inc. (-42.57%),
| Company | ROE | Market cap |
|---|---|---|
| 21.05% | $175.84M | |
| -33.07% | $685.15M | |
| -77.09% | $304.44M | |
| -78.12% | $411.52M | |
| -70.79% | $300.28M | |
| -101.19% | $563.29M | |
| -73.23% | $889.71M | |
| -17.68% | $814.99M | |
| -55.83% | $82.94M | |
| -42.57% | $230.35M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBridge Biosciences using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NovaBridge Biosciences or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is NovaBridge Biosciences's ROE?
How is the ROE calculated for NovaBridge Biosciences (NBP)?
What is the highest ROE for NovaBridge Biosciences (NBP)?
What is the 3-year average ROE for NovaBridge Biosciences (NBP)?
What is the 5-year average ROE for NovaBridge Biosciences (NBP)?
How does the current ROE for NovaBridge Biosciences (NBP) compare to its historical average?